Feature | Heart Valve Technology | June 24, 2019

CMS Finalizes Updates to Coverage Policy for Transcatheter Aortic Valve Replacement

Decision expands access to TAVR in Medicare by modernizing the requirements that providers must meet to perform the cardiac procedure under Coverage with Evidence Development (CED)

CMS Finalizes Updates to Coverage Policy for Transcatheter Aortic Valve Replacement

June 24, 2019 — The Centers for Medicare and Medicaid Services (CMS) recently finalized its decision to update the national coverage policy for transcatheter aortic valve replacement (TAVR), streamlining key elements of the original national coverage determination that went into effect in 2012.

CMS will continue to cover TAVR — a procedure for a condition known as aortic stenosis in which the heart valve that propels blood from the heart to the rest of the body becomes narrowed — under coverage with evidence development (CED) when furnished according to a U.S. Food and Drug Administration (FDA)-approved indication. However, CMS is updating the coverage criteria for hospitals and physicians to begin or maintain a TAVR program. The decision provides greater flexibility for hospitals and providers to meet the requirements for performing TAVR. 

“Today’s decision to update and streamline the TAVR coverage parameters demonstrates CMS’ ongoing commitment to our beneficiaries,” said CMS Administrator Seema Verma. “The modification to the TAVR hospital and physician requirements is generally consistent with the 2018 Consensus Statement from the American College of Cardiology, the American Association for Thoracic Surgery, the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. The decision ensures improved access to care for beneficiaries while supporting the continued evolution of this important technology in light of emerging evidence.”

In developing its decision, CMS met with numerous stakeholders including medical professional societies, who recommended requirements for hospitals and physicians to perform a certain volume of heart procedures. The decision includes updated volume requirements for hospitals and physicians to begin and maintain TAVR programs.

CMS said the decision reflects the current evidence base and strikes an appropriate balance between ensuring that hospitals have the experience and capabilities to handle complex heart disease cases, while limiting the burden and barriers that excessive requirements create for hospitals and patients. CMS will continue to follow efforts by medical societies to develop TAVR-specific outcome measures, and the agency will encourage continued progress toward the establishment of such widely supported measures as potential replacements for procedural volume criteria.

The CMS decision was made in response to a formal request and is consistent with recommendations from a meeting of the MEDCAC (Medicare Evidence Development & Coverage Advisory Committee) on July 25, 2018. The MEDCAC provides CMS with an external review of medical literature, technology assessments, public testimony, and other data and information on the benefits, harms, and appropriateness of therapies under review.

Read the full decision here.

For more information: www.cms.gov

Related Content

News | Cardiovascular Business

May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...

Home May 16, 2022
Home
News | Cardiovascular Business

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new ...

Home May 11, 2022
Home
Feature | Cardiovascular Business

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of April ...

Home May 02, 2022
Home
News | Cardiovascular Business
April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...
Home April 29, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

Home April 29, 2022
Home
News | Cardiovascular Business

April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid ...

Home April 28, 2022
Home
News | Cardiovascular Business

April 21, 2022 – Atlantic Health System’s Morristown Medical Center (MMC) announced that it is offering the first ...

Home April 21, 2022
Home
Subscribe Now